Microsoft Windows up to Server 2019 Azure AD Web Sign-in Local Privilege Escalation

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.9$0-$5k0.00

Summaryinfo

A vulnerability, which was classified as critical, was found in Microsoft Windows up to Server 2019. This affects an unknown part of the component Azure AD Web Sign-in. The manipulation results in an unknown weakness. This vulnerability is cataloged as CVE-2021-27092. An attack on the physical device is feasible. There is no exploit available. Applying a patch is advised to resolve this issue.

Detailsinfo

A vulnerability classified as critical has been found in Microsoft Windows up to Server 2019 (Operating System). Affected is some unknown functionality of the component Azure AD Web Sign-in. This is going to have an impact on confidentiality, integrity, and availability.

The weakness was shared 04/13/2021 as confirmed security guidance (Website). The advisory is shared for download at portal.msrc.microsoft.com. This vulnerability is traded as CVE-2021-27092. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 04/14/2021).

Applying a patch is able to eliminate this problem. A possible mitigation has been published immediately after the disclosure of the vulnerability.

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Productinfo

Type

Vendor

Name

Version

License

Website

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 6.8
VulDB Meta Temp Score: 5.9

VulDB Base Score: 6.8
VulDB Temp Score: 5.9
VulDB Vector: 🔍
VulDB Reliability: 🔍

Vendor Base Score (Microsoft): 6.8
Vendor Vector (Microsoft): 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Local Privilege Escalation
CWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍

Physical: Yes
Local: Yes
Remote: No

Availability: 🔍
Status: Unproven

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Patch
Status: 🔍

Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍

Timelineinfo

02/10/2021 🔍
04/13/2021 +62 days 🔍
04/13/2021 +0 days 🔍
04/14/2021 +0 days 🔍
04/17/2021 +3 days 🔍

Sourcesinfo

Vendor: microsoft.com
Product: microsoft.com

Advisory: portal.msrc.microsoft.com
Status: Confirmed

CVE: CVE-2021-27092 (🔍)
GCVE (CVE): GCVE-0-2021-27092
GCVE (VulDB): GCVE-100-172944
scip Labs: https://www.scip.ch/en/?labs.20161215

Entryinfo

Created: 04/14/2021 06:49
Updated: 04/17/2021 11:06
Changes: 04/14/2021 06:49 (32), 04/14/2021 06:50 (3), 04/14/2021 06:53 (20), 04/17/2021 11:06 (2)
Complete: 🔍
Cache ID: 216::103

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!